Determinants of eye drop size.

Ophthalmic solutions are available for multidose or single-dose administration in a wide variety of glass and plastic dropper bottles which deliver drops with a volume between 25 and 70 microl. From a biopharmaceutical and economic point of view, however, smaller volumes of 5 to 15 microl should be instilled. In this review, the technical, pharmaceutical, and therapeutic aspects of eye drop formation and delivery are presented. The different types of containers are described and the determinants of eye drop size are discussed, such as the design and physical characteristics of the dropper tip and bottle, the physico-chemical properties of the solution, and the manner in which the patient dispenses the drops. Preferred and alternative instillation techniques and aids to facilitate the administration of eye drops by elderly patients are described.

[1]  W. P. Munroe,et al.  Systemic Side Effects Associated with the Ophthalmic Administration of Timolol , 1985, Drug intelligence & clinical pharmacy.

[2]  J. Sorab,et al.  Tactile sensory monitoring of clinician-applied forces during delivery of newborns , 1988, IEEE Transactions on Biomedical Engineering.

[3]  C. M. Lederer,et al.  Drop size of commercial glaucoma medications. , 1986, American journal of ophthalmology.

[4]  R. Brown,et al.  Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. , 1987, Archives of ophthalmology.

[5]  R G Fiscella,et al.  Costs of glaucoma medications. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[6]  R. Huupponen,et al.  Systemic absorption of ocular scopolamine in patients. , 1990, Journal of ocular pharmacology.

[7]  P. Rivers Compliance Aids — Do They Work? , 1992, Drugs & aging.

[8]  A. Flach Systemic toxicity. Associated with topical ophthalmic medications. , 1994, The Journal of the Florida Medical Association.

[9]  J. Cooper,et al.  Cooper and Gunn's Dispensing for Pharmaceutical Students , 1966 .

[10]  J. Robinson,et al.  Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. , 1976, Journal of pharmaceutical sciences.

[11]  J. Lang Ocular drug delivery conventional ocular formulations , 1995 .

[12]  A. Ludwig,et al.  Physicochemical properties, NMR spectroscopy and tolerance of inclusion complexes of antazoline and tetracaine with hydroxypropyl-β-cyclodextrin , 1998 .

[13]  A. Ludwig,et al.  Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  E. Gramer,et al.  Verbesserung der Augentropfenapplikation und Compliance bei Glaukompatienten - Eine klinische Studie , 1997 .

[15]  V. H. Lee Precorneal, corneal, and postcorneal factors , 1993 .

[16]  A. Ludwig,et al.  Influence of the dropper tip design on the size of eye-drops , 2001 .

[17]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[18]  H. Quigley Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[19]  A. Winfield,et al.  A study of the causes of non-compliance by patients prescribed eyedrops. , 1990, The British journal of ophthalmology.

[20]  M. Kass,et al.  Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? , 1986, American journal of ophthalmology.

[21]  G. Mulley,et al.  Practical problems with eye-drops among elderly ophthalmology outpatients. , 1992, Age and ageing.

[22]  A. Robin,et al.  Reformulation and drop size of apraclonidine hydrochloride. , 1992, American journal of ophthalmology.

[23]  P Diggory,et al.  Medical treatment of glaucoma--a reappraisal of the risks. , 1996, The British journal of ophthalmology.

[24]  V. Leirer,et al.  Adherence and Medication Instructions Review and Recommendations , 1988, Journal of the American Geriatrics Society.

[25]  T. F. Patton,et al.  Topically applied pilocarpine. Human pupillary response as a function of drop size. , 1980, Archives of ophthalmology.

[26]  A. Urtti,et al.  Minimizing systemic absorption of topically administered ophthalmic drugs. , 1993, Survey of ophthalmology.

[27]  R G Radwin,et al.  A conductive polymer sensor for measuring external finger forces. , 1991, Journal of biomechanics.

[28]  F. Fraunfelder,et al.  Systemic side effects from ophthalmic timolol and their prevention. , 1987, Journal of ocular pharmacology.

[29]  John G. Webster,et al.  Tactile Sensors for Robotics and Medicine , 1988 .

[30]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[31]  A. Ludwig,et al.  Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes. , 1988, Journal de pharmacie de Belgique.

[32]  Victor C. Strasburger,et al.  Review and Recommendations , 1983 .

[33]  M. Kelly,et al.  A method of drop administration. , 1997, Ophthalmic surgery and lasers.

[34]  N. Carliner,et al.  Respiratory arrest following first dose of timolol ophthalmic solution. , 1983, Chest.

[35]  N. Marquardt Validation of Form-Fill-Seal , 1995 .

[36]  C. Jho,et al.  The effect of viscosity on the drop weight technique for the measurement of dynamic surface tension , 1984 .

[37]  J W Shell,et al.  Pharmacokinetics of topically applied ophthalmic drugs. , 1982, Survey of ophthalmology.

[38]  J. André,et al.  Comparison between estimates of hand volume and hand strengths with sex and age with and without anthropometric data in healthy working people , 1997, European Journal of Epidemiology.

[39]  S. Klyce,et al.  Determination of tear volume and tear flow. , 1966, Investigative ophthalmology.

[40]  O. Olejnik Conventional systems in ophthalmic drug delivery , 1993 .

[41]  D. Holdsworth,et al.  FATE OF CHLORBUTOL DURING STORAGE IN POLYETHYLENE DROPPER CONTAINERS AND SIMULATED PATIENT USE , 1984, Journal of clinical and hospital pharmacy.

[42]  A. Canada,et al.  Relationship of viscosity, contact time and prolongation of action of methylcellulose-containing ophthalmic solutions. , 1965, American journal of hospital pharmacy.

[43]  J. Nelson Corneal abrasion resulting from a unit dose artificial tear dispenser. , 1987, American journal of ophthalmology.

[44]  Stuart F. Ball,et al.  Cost of β-Adrenergic Receptor Blocking Agents for Ocular Hypertension , 1992 .

[45]  J. Diamond,et al.  Systemic Adverse Effects of Topical Ophthalmic Agents , 1997, Drugs & aging.

[46]  J. P. Frangie Clinical Pharmacokinetics of Various Topical Ophthalmic Delivery Systems , 1995, Clinical pharmacokinetics.

[47]  L. Salminen Review: systemic absorption of topically applied ocular drugs in humans. , 1990, Journal of ocular pharmacology.

[48]  G. Merli,et al.  Systemic effects of eye drops. , 1982, Archives of internal medicine.

[49]  R. Brown,et al.  The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine. , 1993, American journal of ophthalmology.

[50]  J. Olesen,et al.  Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues , 1994, Pain.

[51]  A. Rosenthal,et al.  Educating the glaucoma patient. , 1983, The British journal of ophthalmology.

[52]  J. Stevens,et al.  Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing. , 1992, The British journal of ophthalmology.

[53]  E. Palmer How safe are ocular drugs in pediatrics? , 1986, Ophthalmology.

[54]  T. Zimmerman,et al.  Facilitating patient compliance in glaucoma therapy. , 1983, Survey of ophthalmology.

[55]  C. Jho,et al.  Drop weight technique for the measurement of dynamic surface tension , 1983 .

[56]  M. Kelly,et al.  Improving drop administration by patients. , 1996, Journal of ophthalmic nursing & technology.

[57]  R. Glynn,et al.  Falls in elderly patients with glaucoma. , 1991, Archives of ophthalmology.

[58]  R. Brown,et al.  Creating smaller eyedrops by reducing eyedropper tip dimensions. , 1985, American journal of ophthalmology.

[59]  F. Hugues,et al.  Systemic and Local Tolerability of Ophthalmic Drug Formulations , 1993, Drug safety.

[60]  M. Kass,et al.  A miniature compliance monitor for eyedrop medication. , 1984, Archives of ophthalmology.

[61]  E O'Donoghue,et al.  Beta blockers and the elderly with glaucoma: are we adding insult to injury? , 1995, The British journal of ophthalmology.

[62]  A. Loewenstein,et al.  Application of eye drops to the medial canthus , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[63]  S. Yalkowsky,et al.  Review on the systemic delivery of insulin via the ocular route. , 2002, International journal of pharmaceutics.

[64]  W. C. Stewart,et al.  Daily Cost of β-Adrenergic Blocker Therapy , 1997 .

[65]  Annick Ludwig,et al.  Dispensing eye drops from flexible plastic dropper bottles. Part I : Influence of the packaging characteristics , 1999 .

[66]  J. Parkin,et al.  The Effect of Disodium Edetate and Sodium Chloride on the Stability of Ethylmercury Arising from the Decomposition of Thimerosal (Thiomersal) , 1995 .

[67]  R. Brown,et al.  Design of eyedropper tips for topical beta-blocking agents. , 1986, American journal of ophthalmology.

[68]  Letocha Ce Methods for self-administration of eyedrops. , 1985 .

[69]  W. Hook,et al.  Assessment of thumb to index pulp to pulp pinch grip strengths. , 1986, Journal of hand surgery.

[70]  J. Gaddum,et al.  United States Pharmacopeia , 1955, Nature.

[71]  E P O'Sullivan,et al.  Prescription of eye drops , 2001, Postgraduate medical journal.

[72]  T. F. Patton Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume. , 1977, Journal of pharmaceutical sciences.

[73]  Camilo Escobar,et al.  Drop Size and Systemic Adverse Effects in Timolol Ophthalmic Solution , 1990, DICP : the annals of pharmacotherapy.

[74]  J. Robinson,et al.  Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.

[75]  J. Webster,et al.  A silicon-based tactile sensor for finger-mounted applications , 1998, IEEE Transactions on Biomedical Engineering.

[76]  A. Ludwig,et al.  The influence of penetration enhancers on the volume instilled of eye drops. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[77]  A. Corlett Caring for Older People: Aids to compliance with medication , 1996, BMJ.

[78]  G. Petursson,et al.  Treatment of glaucoma using minidrops of clonidine. , 1984, Archives of ophthalmology.

[79]  John W. Shell Ophthalmic drug delivery systems , 1984 .